🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1b open-label study to investigate the safety and maximum t...
Status
Completed
Location
Sarcoma Oncology Center
Start Date
2012-07
Trial ID
NCT01673438
Treatments Being Tested
This is a randomized open-label phase 2 study to evaluate the efficacy and ...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-09
Trial ID
NCT03554109
This is a Phase 1 study to investigate the safety and activity of aldoxorub...
Status
Completed
Location
Virginia G. Piper Cancer Center
Start Date
2014-08
Trial ID
NCT02235688
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of aldoxo...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-01
Trial ID
NCT02049905
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-05-25
Trial ID
NCT03563170
This is a Phase 1 open-label study to study the safety and activity of aldo...
Status
Completed
Location
Sarcoma Oncology Center
Start Date
2014-09-02
Trial ID
NCT02235701
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-07-17
Trial ID
NCT03586869
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2017-12-28
Trial ID
NCT03387098
This is a pilot study to determine the efficacy and safety of aldoxorubicin...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2014-03
Trial ID
NCT02014844
Treatments Being Tested
QUILT-3.088 NANT Pancreatic Cancer Vaccine: Phase II Randomized Trial of th...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-08
Trial ID
NCT03563144